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Ten monoclonal antibodies (MAbs) were prepared against the nonstructural protein sNS of avian reovirus S1133. Eight of
them were selected for two-way competitive binding assay after coupling with horseradish peroxidase. The results allowed
the definition of three epitopes, designated A, B, and C. Blocking assay of poly(A)–Sepharose binding activity of sNS with
MAbs indicated that MAb recognizing epitope B was able to block poly(A) oligomer binding, suggesting that epitope B is
involved in ssRNA binding of sNS. An immuno-dot binding assay was used to analyze the effect of denaturation on antibody
recognition of the epitopes. All MAbs bound to protein sNS in its native form. After denaturation by boiling in SDS and
2-mercaptoethanol, the binding of MAbs recognizing epitopes B and C was not affected. The reactivity of MAbs recognizing
epitope A was fully abolished by denaturation. These results suggest that the binding of MAbs directed against epitope A is
conformation-dependent; however, the recognition by MAbs of epitopes B and C is not conformation-dependent. In addition,
the results from the cross-reactivity of MAbs to heterologous avian reovirus strains suggest that the three epitopes are highly
conserved among these virus strains. © 2001 Academic Press
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sINTRODUCTION
Avian reovirus (ARV), physically and biochemically
similar to mammalian reovirus (MRV), which is the pro-
totype of the genus orthoreovirus (Gouvea and Schnitzer,
1982; Wickramasinghe et al., 1993), has a genome con-
sisting of 10 segments of double-stranded RNA (dsRNA),
enclosed by a double-shell capsid. All virus-encoded
proteins and their coding assignments have been dem-
onstrated by using an in vitro translation system with
each individual viral genome segment as the templates
(Varela and Benavente, 1994). Virus encoded at least 10
primary translation products; 8 of these products are
structural proteins and the other 2 are nonstructural.
Compared to MRV, proteins of ARV are much less
characterized. Protein sC is structurally equivalent to
rotein s1 of MRV and is the target for type-specific
neutralizing antibodies (Wickramasinghe et al., 1993),
hile antibodies against sB are group-specific (Take-
hara et al., 1987; Shapouri et al., 1996). Both proteins are
involved in the induction of cell fusion when the cells are
infected (Ni and Ramig, 1993; Theophilos et al., 1995).
Recently, ARV sA, encoded by the ARV S2 gene and a
ounterpart to MRV s2, has been reported for its dsRNA
inding activity (Yin et al., 2000; Martinez-Costas et al.,
000) and possible involvement in resistance to inter-
eron (Martinez-Costas et al., 2000). Another protein of
RV, sNS, encoded by the S4 gene (Chiu and Lee, 1997),
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168has been identified as a single-stranded RNA (ssRNA)
binding protein (Yin and Lee, 1998, 2000), similar to its
MRV counterpart sNS. The ssRNA binding activity may
play a role in viral mRNA assortment and packaging, as
described for MRV (Huismans and Joklik, 1976; Antczak
and Joklik, 1992). No observations regarding the
epitopes of ARV sNS and their relatedness to viral bio-
logical activities are reported.
In the present study, 10 monoclonal antibodies (MAbs)
directed against ARV sNS were produced. To map the
pitopes reacting with the MAbs we performed recipro-
al competitive binding assays. The results allow our
emonstration of the existence of at least three epitopes
n sNS. The sensitivity to denaturation of the epitopes
responsible for antibody binding was analyzed with the
MAbs in an immuno-dot binding assay. The epitopes’
involvement in ssRNA binding and the variability of these
epitopes in different ARV strains were analyzed.
RESULTS
Production and characterization of MAbs
Spleen cells from three mice immunized with poly(A)–
Sepharose-purified viral sNS were fused in independent
experiments. At 10 to 14 days after fusion, the hybridoma
cell lines secreting anti-sNS MAbs were screened by
LISA using the purified sNS as the coating antigen.
ighteen MAbs directed against sNS were selected for
ubcloning at least three times at the limiting dilution.
ybridomas from 13 of 18 subclones were selected to
roduce MAbs in mice and their ascitic fluids were used
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169NONSTRUCTURAL PROTEIN sNS EPITOPES OF ARV S1133for further characterization (Table 1). The isotype of all
MAbs was IgG class. The predominant isotype was IgG1
(12), whereas only 1 MAb, 5F9, was IgG2a. Concentra-
tions of immunoglobulin ranged from 0.32 to 13.87 mg/
ml. Their peptide specificity was determined by immuno-
precipitation of [35S]methionine-labeled viral-specific
roteins. A representative result is shown in Fig. 1. A
ajor viral protein comigrating with viral protein sNS
Fig. 1, lane V) was specifically precipitated by all se-
ected MAbs, but the protein bands exhibited various
ntense signals. Nonproportional concentration between
sNS in cell extracts and MAbs may contribute to this
difference, particularly in the immunoprecipitates with
MAb 4A123 that produced a fairly faint signal (Fig. 1, lane
8). Additionally, backgrounds with several minor protein
TABLE 1
Properties of Monoclonal Antibodies Directed against the
Nonstructural Protein sNS of ARV-S1133
Hybridoma
cell line
Isotype
specificity
Ascitic Ig
(mg/ml)a
4C7 IgG1 2.49
Gall IgG1 0.57
H1E1 IgG1 13.87
1F9 IgG1 10.5
5F9 IgG2a 0.32
4B9 IgG1 4.58
4A23 IgG1 13.1
4A125 IgG1 12.8
4A123 IgG1 12
4A21 IgG1 3.15
L2G10 IgG1 10.2
C4G10 IgG1 9.8
C2G3 IgG1 11.2
a Concentration of ascitic immunoglobulin precipitated with ammo-
nium sulfate was determined according to Bio-Rad standard assay
procedures.
FIG. 1. Immunoprecipitation of cell extracts of [35S]methionine-la-
beled CEF infected with ARV-S1133. Lanes 1–10 contain immunopre-
cipitates with MAbs 47C, 4A21, 4A125, 4A23, 1F9, 4B9, Gall, 4A123, 5F9,
and H1E1, respectively. Lanes V and C contain virus- and mock-infected
cell extracts, respectively. The positions of bands corresponding to ARV
peptides (Varela and Benavente, 1994) are indicated on the left.bands could be coprecipitated with MAbs L2G10, C4G10,
and C2G3 (data not shown). This could be because those
MAbs are not from a single clone, even having been
subcloned three times. They were thus not used for the
additional assay.
Nature of the epitopes on sNS
To determine the need for a native structure for anti-
body binding, an immuno-dot binding assay was carried
out on native or denatured sNS. All MAbs recognized
sNS in its native structure, i.e., in TNE buffer. After
denaturation by boiling in SDS and 2-mercaptoethanol
(2-ME), the MAbs 1F9, 4C7, H1E1, and Gall, recognizing
epitopes B and C, still bound to the proteins. The reac-
tivities of MAbs 4A21, 4A125, 4A23, 4B9, 4A123, and 5F9,
recognizing epitope A, however, were fully abolished by
denaturation (Fig. 2). Similar results were obtained from
the Western immunoblotting assay. sNS was denatured
with SDS and 2-ME and subjected to SDS–PAGE. Pro-
teins immobilized on nitrocellulose membranes were
then probed with all MAbs. MAbs H1E1, 1F9, 4C7, and
Gall bound to sNS, while others showed no or weaker
inding (data not shown).
vidity of MAbs to sNS and mapping of the epitopes
Absorbances reflected the numbers of MAbs bound to
he proteins when the reaction reached at the plateau
nd could be used to estimate the relative avidity of
Abs for their respective proteins (Stone and Nowinsk,
980; Lefrancois and Lyles, 1982). Binding characteris-
ics of MAbs to sNS were determined by an ELISA
titration. Binding curves of MAbs used in competitive
binding assay were made. As shown in Fig. 3, all MAbs
apparently saturated protein sNS at dilutions from 1:10 to
:103.6.
FIG. 2. Immuno-dot binding of MAbs to sNS of ARV-S1133 in its
ative state (N) or denatured with SDS and 2-ME (D). Approximately 1
mg of purified sNS was applied as a dot on nitrocellulose membrane
and probed with MAbs as indicated. Mouse anti-sNS of ARV-S1133
hyperimmune serum (PC) and preimmune serum (NC) were used as
positive and negative controls, respectively. The binding was visualized
with a HRP-labeled second antibody as described under Materials and
Methods.To determine whether the MAbs could be divided into
clusters recognizing the same immunogenic region of
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170 HOU ET AL.sNS, all MAbs except MAbs 5A9 and Gall listed in Table
1 retained their binding capacity after coupling to horse-
radish peroxidase (HRP) (data not shown). The avidity of
the latter MAbs apparently is too low in the ELISA and
they were used only as the competitors in one-way
competition. Consequently, the remaining eight MAbs
were used in the antibody competition assays. Dose–
response curves for the unconjugated and the HRP-
conjugated MAbs were plotted to determine the proper
concentrations for the competitive binding assay. Each of
the eight MAbs was used both as a competitor and as a
HRP-conjugated probe. MAbs were considered to recog-
nize the same epitope if use of reciprocal antibody prep-
arations prevented binding. The percentage of competi-
tion was normalized 100% in the homologous reaction.
Three epitopes on sNS were defined by these MAbs
Fig. 4 and Table 2), which were designated A, B, and C.
one-way competition was observed between MAbs
ecognizing epitope B and that recognizing epitope C. In
ddition, when MAbs 5F9 and Gall were used as the
nconjugated competitors, MAb 5F9 competed for
pitope A with MAbs that recognized epitope A but not
FIG. 3. Avidity assay of the MAbs against the ARV S1133 nonstruc-
tural protein sNS. Serial twofold dilutions of MAbs were incubated with
protein sNS adsorbed on the well of microtiter plates. After removal of
unbound MAbs, the binding to sNS was detected by the addition of
RP-labeled rabbit anti-mouse IgG (H1L). The resulting A 405 was read
and used to rate MAbs for avidity.pitopes B and C, while MAb Gall competed for epitopes
and C with MAbs that recognized the same epitope.
M
1ross-reactivity of MAbs to heterologous ARV strains
Three representative MAbs, 4A123, 1F9, and H1E1,
ecognizing epitopes A, B, and C, respectively, were
elected to test for their cross-reactivity with other ARV
trains in the ELISA. Three commercial vaccine strains of
RV (S1133, 1733, and 2408; Solvay, Inc.) and six local
solates (1017-1, 916SI, 918, T6, 919, and R2) were used
or this test. On the basis of cross-neutralization tests,
trains S1133, 1733, 2408, 916SI, and R2 have been
rouped into serotype 1, while strains 918 and T6 repre-
ent two additional different serotypes. The other two
irus strains remain unclassified (Lee et al., 1992). The
esults indicated that sNS in cell extracts prepared from
hicken embryo fibroblasts (CEF) infected with each het-
rologous ARV strain was captured by anti-sNS anti-
serum. The relative binding of each MAb to heterologous
virus strains was found to be more than 75%. Thus, MAbs
4A123, 1F9, and H1E1 strongly recognized all tested
strains, indicating that these epitopes were highly con-
served among sNS of ARV strains (Fig. 5).
Blocking of ssRNA binding activity of sNS with MAbs
Three representative MAbs, 4A123, 1F9, and H1E1,
ecognizing epitopes A, B, and C, respectively, were
elected to block ssRNA binding activity of sNS. This
was performed on the protein sNS that had been prein-
cubated with preimmune serum or MAb 4A123, 1F9, or
H1E1, followed by poly(A)–Sepharose binding and the
bound protein analysis. The results showed that MAb
1F9 (Fig. 6) and mouse monospecific antiserum to sNS
(Fig. 6, lane 6) blocked binding of RNA to sNS, whereas
preimmune serum (Fig. 6, lane 5) and MAbs H1E1 and
4A123 (Fig. 6) had no effect. In addition to the protein
band of sNS, two additional visible bands with lower or
higher molecular weight than sNS were observed in the
amples containing MAbs. These bands were probably
he products (light or heavy chain) of IgG of MAbs which
ad been retained in the Sepharose beads after wash-
ng, as they were also evident in the sample which
ontained Sepharose without poly(A) oligomer (Fig. 6,
ine 8). Another visible band with the highest molecular
eight was also recognized. This could be due protein
olecules in the samples that were not well dissociated
y boiling after trichloroacetic acid precipitation.
DISCUSSION
In this paper we described properties of MAbs di-
ected against protein sNS of ARV S1133. Competitive
binding assay using all 10 MAbs was conducted to
analyze epitopes on sNS. The definition of epitopes by
his assay is based on the assumption that a MAb bind-
ng to a specific site hinders the attachment of anotherAb to the same or a proximal site (Stone and Nowinski,
980; Niesters et al., 1987). However, two MAbs directed
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171NONSTRUCTURAL PROTEIN sNS EPITOPES OF ARV S1133against to the same site will compete in a manner related
to their relative avidities and concentrations. Thus, a
spectrum of relative interference efficiencies will be ob-
tained (Stone and Nowinski, 1980; Lefrancois and Lyles,
1982). The results from two-way competition are signifi-
cant for the determination of MAbs recognizing the same
epitopes, even when the degree of competition is low.
Eight of 10 MAbs clearly delineated three epitopes, A, B,
and C, on the sNS; MAbs belonging to epitope A, B, or C
inhibited almost completely the binding of HRP-labeled
MAbs recognizing the same epitope, and no competition
was observed among MAbs recognizing epitope A, B, or
C. An exception was the one-way competition observed
between epitopes B and C. This does not necessarily
FIG. 4. Competitive binding assay with HRP-conjugated MAbs to sN
he plates were incubated with HRP-labeled MAbs to which serial dilut
ere calculated from OD405 in the presence of competitor and that in
the concentration of competitor. HRP-conjugated MAb is marked withindicate overlap of the epitopes, but may also be the
result of conformation changes in the protein sNS in-duced by a MAb against one epitope, leading to a re-
duced binding of a MAb to another epitope. In addition,
MAbs 5F9 and Gall competed with the MAbs recognizing
epitope A or epitopes B and C, respectively, when they
were used as the unconjugated competitors in one-way
competition. However, both MAbs lost their sNS-binding
activity after HRP conjugation; recognition of epitope by
both MAbs remained unclassified.
The role of the conformation of sNS in MAb binding
as characterized by immunoblot-dot assay. All 10 MAbs
howed binding activities to sNS in native conformation
(Fig. 2). When the protein conformation was disrupted by
SDS and 2-ME, and the protein was probed with MAbs,
the binding of MAbs recognizing epitope A was com-
V-S1133. Purified sNS was adsorbed in the wells of microtiter plates.
the competitor MAbs had been added. The percentages of competition
ence of competitor as described in the text and were plotted againstS of AR
ions ofpletely abolished. Similar results were obtained in West-
ern blotting assay. The results indicate that recognition of
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172 HOU ET AL.the MAbs directed against epitope A required the native
conformation of sNS and, apparently, their binding activ-
ties were conformation-dependent. On the other hand,
pitopes B and C defined by other MAbs were resistant
o the treatment of SDS and 2-ME. Therefore, binding
ctivity of MAbs to epitopes B and C was not conforma-
ion-dependent.
Epitope B is involved in ssRNA binding, as its corre-
ponding MAb 1F9 can block ssRNA binding of sNS.
T
Results of Competitive Binding Assay between Mono
Competitor
HRP
4A123 4A21 4A23 4B9
4A123 11 11 11 11
4A21 11 11 11 11
4A23 11 11 11 11
4B9 11 11 11 11
4A125 11 11 11 11
1F9 2 2 2 2
4C7 2 2 2 2
H1E1 1 1 2 2
5F9 1 11 1 1
Gall 2 2 2 2
Note. Competition more than 60%, 11; competition between 35 and
all was not classified (U).
FIG. 5. Cross-reactivity of MAbs to sNS of ARV S1133 with heterol-
ogous ARV isolates. Chicken polyclonal antibody against ARV S1133
and HRP-conjugated goat anti-chicken antiserum were used as pri-
mary and secondary antibodies, respectively, to detect the presence of
sNS in each cell extract. HRP-coupled MAbs were used directly as the
primary antibodies. The relative binding to heterologous ARV isolates is
expressed as a percentage by taking the A 405 obtained with ARV S1133
n the reaction as 100. Binding was considered strong if it was more
han 50%, significant if it was 25 to 50%, and negative if it was less than
5%.MAb 1F9 reacted with all heterologous ARV strains.
Thus, this epitope is commonly shared by the ARV
strains. Conservation of epitope B may not be unex-
pected in view of the biological function of sNS. It has
een shown that ARV sNS, similar to its counterpart sNS
f MRV, binds to ssRNA to form nucleoprotein complexes
oon after transcription. Additionally, genome segment
ssortment into progeny genome and minus-strand syn-
hesis may be intimately linked (Antczak and Joklik,
992). Thus, epitope B with ssRNA binding activity is
mportant in the initial stage of ARV replication. Epitopes
and C were not involved in any known biological
unction, but they were highly conserved among ARV
trains.
Antibodies to ARV S1133 Nonstructural Protein sNS
d Mab
EpitopeA125 1F9 4C7 H1E1
11 2 2 2
11 2 2 2
11 2 2 2 A
11 2 2 2
11 2 2 2
2 11 11 2
B
2 11 11 2
2 11 11 11 C
1 2 2 2
U
2 11 11 1
; competition less than 35%, 2. Epitope recognized by MAbs 5F9 and
FIG. 6. Blocking of ssRNA binding activity of sNS with MAbs 1F9,
1E1, and 4A123. Protein sNS (5 mg) was preincubated with monoclo-
al antibodies at a dilution of 1:5 (lane 2), 1:500 (lane 3), or 1:5000 (lane
); preimmune mouse serum (lane 5); or mouse anti-sNS monospecific
antiserum (lane 6). The reaction mixtures were mixed with poly(A)–
Sepharose. Proteins bound to poly(A) were separated by SDS–PAGE,
electrotransferred onto nitrocellulose membrane, and probed with MAb
1F9. Sepharose without poly(A) oligomer was incubated with sNS (5
mg) (lane 7) or with the reaction mixtures in which sNS (5 mg) had
preincubated with MAb 1F9 at 1:5 (lane 8). Lane 1 represents theABLE 2
clonal
-labelesample that contains poly(A)–Sepharose and sNS without antibodies.
sNS is indicated by an arrow.
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173NONSTRUCTURAL PROTEIN sNS EPITOPES OF ARV S1133To date, the region of ARV sNS which is responsible
or ssRNA binding has not been defined. The first 11
mino acid residues at the N-terminus of MRV sNS have
een shown to be a highly conserved region among
hree serotypes of MRV (Wiener and Joklik, 1987) and are
mportant for its ssRNA binding because this region was
lso predicted to form an amphipathic a-helix (Gillian
nd Vibert, 1998). However, the nature of the amphi-
athic-helical structure at the N-terminal sequence in
RV sNS is not conserved in several fusogenic or-
thoreovirus sNS, including ARV, and may not be required
or ssRNA binding (Duncan, 1999). Preparation of deleted
utant proteins of ARV sNS along with the MAbs de-
cribed here may illustrate the site responsible for ss-
NA binding of sNS.
MATERIALS AND METHODS
Cells and virus
All ARV strains were adapted in CEF and plaque-
purified as described previously (Wu et al., 1994).
Purification of ARV protein sNS and immunization of
mice
The procedures for the purification of protein sNS of
ARV were followed essentially as described previously
(Yin and Lee, 1998). Vaccine strain S1133 of ARV (Vine-
land Laboratories) was propagated in confluent CEF
monolayers for 18 h. The cells were lysed, and cytoplas-
mic extracts were prepared. Poly(A)–Sepharose (Phar-
macia) was added to purify protein sNS by taking ad-
antage of its ssRNA binding capacity. The identity of the
urified proteins was then determined using monospe-
ific antibody against ARV sNS prepared previously as a
probe (Yin and Lee, 2000).
BALB/c mice (Laboratory Animal Center, School of
Medicine, National Taiwan University, Taiwan) were
primed intraperitoneally with 25 mg of purified sNS in 0.3
l complete Freund’s adjuvant and boosted twice at
-week intervals with the same amount of antigens in
ncomplete Freund’s adjuvant. At least 7 weeks after the
nitial immunization and 4 days before the mice were
acrificed for the preparation of hybridoma, they were
oosted intraperitoneally with 10 mg of sNS (0.2 ml in
phosphate-buffered saline (PBS)).
Monoclonal antibody production
MAbs were produced using techniques similar to
those described by Lee (1990). Briefly, BALB/c mice im-
munized with sNS as described above were sacrificed,
he spleens were removed, and the splenocytes were
used with NS1 myeloma cells. After antibody-secreting
ybridoma cell lines were screened, they were sub-
loned at least three times by a limiting dilution tech-
t
eique and ascitic fluid was produced with the cloned
ybridomas in Pristane (Sigma)-primed mice.
ntibody screening
Hybridoma culture fluids and mouse ascitic fluids
ere screened for antibodies in an indirect ELISA as
escribed under Antibody binding assay. Further confir-
ation of the virus-specific MAbs was performed by
mmunoprecipitation.
sotype determination
The immunoglobulin class of the hybridoma antibod-
es present in the individual ascitic fluids of the mouse
as determined by ELISA with a Zymed Mab kit. Rabbit
ntisera to mouse IgM, IgG1, IgG2a, IgG3, and IgA and
oat anti-rabbit IgG serum conjugated with horseradish
eroxidase were contained in the kit. Methods for the
etermination were provided by Zymed Ltd.
estern immunoblotting and immuno-dot binding
ssay
The binding of MAbs to denatured specific protein
sNS was examined using Western immunoblotting. Viral
protein sNS purified by poly(A)–Sepharose was sub-
ected to SDS–PAGE (Laemmli, 1970) in 10% polyacryl-
mide gels and electrotransferred to nitrocellulose mem-
ranes. The membranes were probed with MAbs fol-
owed by reaction with HRP-conjugated goat anti-mouse
mmunoglobulin. The binding reaction was detected by
he addition of the diaminobenzidine color development
eagent (0.05% diaminobenzidine, 0.005% hydrogen per-
xide in distilled water) as previously described (Yin et
l., 2000). The same sNS preparation was used for im-
uno-dot binding assay. Antigens were prepared either
y dilution with TNE buffer (0.01 M Tris–HCl, 0.1 M NaCl,
.001 M EDTA, pH 7.4) or by boiling for 5 min in a solution
ontaining 2% SDS and 5% 2-ME (Lee, 1990). Antigens
approximately 1 mg) spotted onto nitrocellulose mem-
brane using a 96-well filtration manifold (Bio-Rad) were
probed with MAbs and the binding reactions were de-
tected by the procedures described above.
Immunoprecipitation
The procedures for labeling of ARV-infected cells with
[35S]methionine were followed essentially as described
Yin and Lee, 1998). Briefly, CEF monolayers were in-
ected with ARV S1133 or mock infected with medium
lone (M199 supplemented with 2% fetal calf serum) and
abeled with [35S]methionine (Amersham Life Science; sp
act . 1000 Ci/mmol; 100 Ci in 5 ml Dulbecco’s modified
agle’s medium without methionine). The cells were
ysed and cytoplasmic extracts were prepared by cen-
rifugation at 12,000 rpm for 20 min. A volume of 60 ml of
xtracts was mixed with 40 ml of ascitic fluids and incu-
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174 HOU ET AL.bated overnight at 4°C. Forty microliters of protein
G–agarose (Boehringer Mannheim) was added and in-
cubated overnight at 4°C with gentle rotation. The pellet
was washed three times in a buffer containing 50 mM
Tris–HCl (pH 7.5), 500 mM NaCl, 0.1% NP-40, 0.05% so-
dium deoxycholate. Proteins were eluted from the beads
by boiling the sample buffer and analyzed by SDS–PAGE
and autoradiography.
Coupling of horseradish peroxidase to monoclonal
antibodies
Immunoglobulin fractions were isolated from ascitic
fluids by precipitation at 4°C with an equal volume of
saturated ammonium sulfate (pH 7.0), dialyzed against
PBS overnight with several changes, and then purified
using an affinity column of protein G–agarose (Boehr-
inger Mannheim). Antibodies were coupled to HRP by
the periodate method (Wilson and Nakane, 1978) and
stored at 220°C.
Determination of protein concentration
The concentration of ARV protein sNS purified by
poly(A)–Sepharose and immunoglobulin isolated from
ascitic fluids was determined according to the Bio-Rad
standard assay procedures.
Antibody binding assay
The amount of binding in the ELISA was determined
for all HRP-unconjugated and -conjugated MAbs, prior to
carrying out the competitive binding assay. For HRP-
unconjugated MAb determination, microtiter plates were
coated with 0.1 mg purified sNS in 100 ml coating buffer
(50 mM carbonate, pH 9.6) per well at 37°C for 2 h and
washed three times with washing buffer (0.01 M PBS, pH
7.2, 0.05% Tween 20). A volume of 100 ml of TNE buffer
ontaining 2.5% bovine serum albumin was added to
ach well to saturate all unbound sites. After three
ashes, 100 ml of purified MAb serially diluted with TNE
uffer containing 1% bovine serum albumin was added
nd incubated for 2 h at 25°C. After washing, 50 ml of a
1:3000 dilution of HRP-conjugated goat anti-mouse IgG
(L1H) serum (Jackson) was added and incubated for
another 1 h. Following final washing, 50 ml of a freshly
prepared solution containing 0.5 mM citric acid (pH 4.0),
2.3 mM H2O2, 40 mM 2,29-azinobis-3-ethylbenzthiazoline
ulfonic acid (Sigma) was added to each well. The en-
yme activity was terminated after 20 min of incubation
y the addition of 30 ml of 1% sodium azide. The absor-
ance was measured at 405 nm on an ELISA reader
Dynatech). For HRP-conjugated MAb determination, the
ame procedures were carried out except that HRP-
onjugated MAbs were directly added to the antigen-
oated plates without using the HRP-conjugated goat
nti-mouse antiserum. The resulting dose–response
urve yielded the level of maximum binding for the rela-
t
cive avidity measurement and the MAb concentration at
hich 50% binding occurred.
To test the MAbs for their cross-reactivity with other
RV strains in the antigen-capture ELISA, 200 ml (1:200)
of mouse anti-sNS antiserum (Yin and Lee, 2000) was
coated onto ELISA plates. After washing and blocking
with bovine serum albumin, 100 ml of cell extracts from
CEF infected with each ARV isolate or from mock-in-
fected cells was added and incubated at 37°C for 2 h.
For the reaction of MAbs, 50 ml of HRP-conjugated MAb
F9, MAb 4A123, and MAb H1E1 was added as the
rimary antibodies. To determine if sNS present in cell
xtracts from CEF cells infected with each ARV isolate
as captured by mouse anti-sNS antiserum, chicken
ntiserum against ARV S1133 (Lee et al., 1992) and HRP-
conjugated goat anti-chicken antiserum (Jackson) were
used as primary and secondary antibody, respectively.
Absorption was measured at 405 nm. The relative bind-
ing to the heterologous virus is expressed as a percent-
age by taking the absorbance obtained with ARV S1133
in the reaction as 100. Binding was rated as strong if it
was more than 50%, significant if it was 25 to 50%, and
negative if it was less than 25%.
Competitive binding assay
The procedures for the competitive binding assay
were the same as described above, except that a mixture
of the HRP-conjugated MAb at twice the concentration
giving half maximal binding and the unconjugated, com-
peting antibody at various concentrations from the linear
part of the dose–response curve were added simulta-
neously in place of HRP-conjugated goat anti-mouse
antiserum. Nonspecific binding to plates without anti-
gens was taken to represent background. The amount of
competitive binding was estimated from the absorbance
at 405 nm in the presence or absence of unconjugated
competing antibodies. The percentages of competition
were calculated using the formula 100( A 2 n)/( A 2 B)
as described by Kimura-Kuroda and Yasui (1983), in
which A is the optical density in the absence of a com-
peting antibody, B is the OD in the presence of a homol-
ogous antibody at 1:10 or 1:100, and n is the OD in the
presence of a competitor.
To define epitope groups, competition was considered
to be positive only when similar results were obtained
when the antibody was used as competitor and as HRP-
coupled antibody. Competition was rated as strong (11)
if it was more than 60%, significant (1) if it was more than
35%, and negative (2) if it was less than 35%.
Binding of sNS to poly(A)–Sepharose in the presence
f MAbs
To determine if the epitopes of sNS were involved in
he ssRNA binding, in the initial experiments various
oncentrations of MAbs were used to test the blocking
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175NONSTRUCTURAL PROTEIN sNS EPITOPES OF ARV S1133activities of binding of sNS to ssRNA probes in gel shift
nalysis (Richmond et al., 1998) or Northwestern tech-
iques (Dermody et al., 1991). Poor results were obtained
s the probes were almost completely degraded (data
ot shown). The degradation of ssRNA probe could be
ue to RNase activity present in the antibody solution.
herefore, purified sNS (5 mg) was incubated with vari-
ous dilutions of MAbs in a total volume of 10 ml at 37°C
for 1 h. The reaction mixtures and poly(A)–Sepharose
(Pharmacia) containing 55 mg poly(A) oligomer were
combined with a binding buffer (150 mM NaCl, 1 mM
DTT, 0.5% Tween 20, 20 mM Hepes, 5 mM MgOAc, 10%
glycerol, pH 7.4) for a total volume of 150 ml and incu-
ated at 25°C for 15 min. After four washes with binding
uffer, proteins bound to the poly(A)–Sepharose were
luted with binding buffer containing 1 M NaCl. Eluted
roteins were separated by SDS–PAGE after precipita-
ion with 10% trichloroacetic acid and electrotransferred
nto nitrocellulose membrane. The nature of proteins
mmobilized on the membrane was detected by using a
onfirmation-independent MAb 1F9 as the probe.
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